Australia markets open in 4 hours 14 minutes

Oryzon Genomics S.A. (ORYZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.41000.0000 (0.00%)
As of 11:18AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Cost of revenue
-13,948
-13,948
-15,234
-9,870
-8,995
Gross profit
13,948
13,948
15,234
9,870
8,995
Operating expenses
Selling general and administrative
-
-
17,616
13,069
9,677
Total operating expenses
18,497
18,497
20,724
16,876
13,284
Operating income or loss
-4,549
-4,549
-5,490
-7,007
-4,290
Interest expense
1,894
1,894
1,119
455.572
469.088
Income before tax
-6,104
-6,104
-6,557
-7,180
-4,779
Income tax expense
-2,751
-2,751
-2,325
-2,493
-1,379
Income from continuing operations
-3,353
-3,353
-4,231
-4,687
-3,400
Net income
-3,353
-3,353
-4,231
-4,687
-3,400
Net income available to common shareholders
-3,353
-3,353
-4,231
-4,687
-3,400
Basic EPS
-0.07
-
-0.08
-0.09
-0.06
Diluted EPS
-0.07
-
-0.08
-0.09
-0.06
Basic average shares
58,742
-
56,042
52,762
52,762
Diluted average shares
58,742
-
56,042
52,762
52,762